Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Assessment of early changes in 3H-fluorothymidine uptake after treatment with gefitinib in human tumor xenograft in comparison with Ki-67 and phospho-EGFR expression

Figure 1

Microscopy images of immunohistochemically stained EGFR (A-C) and Ki-67 (D-F) in tumor. Control, Gefitinib 100, and Gefitinib 200 indicate the control group, group treated with 100 mg/kg gefitinib, and group treated with 200 mg/kg gefitinib, respectively. Values given are mean ± SD.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us